We recently published a list of Top 10 Best Dividend Stocks on Robinhood. In this article, we are going to take a look at ...

Merck (MRK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

The healthcare giant is dealing with the fast-approaching patent cliff for its most important product, cancer medicine ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...